MTOR and gastric cancer: Other studies have shown that gastric cancer-derived MSCs activate the AKT/c-Myc/mTOR pathway in gastric cell lines and upregulate CD276 expression, thereby promoting the migration of gastric cancer cells (Gao et al., 2023).